November 2019 – Clinical Trial Results

Dr. John Spertus and Dr. Adam T Phillips Discuss: International Study of Comparative Health Effectiveness With Medical and Invasive Approaches: Primary Report of Quality of Life Outcomes

November 18, 2019

Disclosures: TBA

Dr. Roxana Mehran, Dr. Christopher Granger, Dr. Gabriel Steg and Dr. C. Michael Gibson Discuss: Antiplatelet Therapy in Acute Coronary Syndromes – Recent Trials Reviewed & Clinical Application of Evidence

November 18, 2019

This is an educational video and is not intended to promote any drug or device in either a labeled or […]

Dr. Kevin Bainey and Dr. Robert Welsh Present: AHA 2019 Wrap-Up from the Canadian Perspective

November 18, 2019

Disclosures: TBA

Dr. Renato Lopes and Dr. Roberto Giraldez Present: AHA 2019 Wrap-Up in Portuguese

November 18, 2019

Disclosures: TBA

Dr. Pierre Amarenco and Dr. Adam T Phillips Discuss: Benefit of a Target LDL Cholesterol Less Than 70 mg/dl After an Ischemic Stroke of Atherosclerotic Origin, the Treat Stroke to Target Trial Results

November 18, 2019

Disclosures: TBA

Dr. Christie Ballantyne and Dr. Adam T Phillips Discuss: ASCVD Reduction and Lipid Lowering Therapies

November 18, 2019

Disclosures: TBA

Dr. Jennifer Robinson and Dr. C.Michael Gibson Discuss: The Evolving Landscape of PCSK9 Inhibitors

November 18, 2019

Disclosures: TBA

Prof. Philip Aylward Presents: AHA 2019 Wrap-Up from the Perspective of the Pacific Rim

November 18, 2019

Disclosures: TBA

Ms. Katherine Wilemon, Founder and CEO of the FH Foundation, and Dr. C. Michael Gibson Discuss: Familial Hypercholesterolemia – A Deep Dive – Sponsored by an independent educational grant from The Medicines Company

November 18, 2019

Disclosures: TBA

Dr. George Dangas and Dr. C. Michael Gibson Discuss: GALILEO: Global Comparison of a Rivaroxaban-Based Antithrombotic Strategy versus an Antiplatelet-Based Strategy After Transcathether Aortic Valve Replacement to Optimize Clinical Outcomes: Primary Results

November 17, 2019

Disclosures: TBA